Hema Now | Episode 14
This week, Jonathan is joined by Shaji Kumar, an expert in hematology and oncology, particularly multiple myeloma, who has made significant contributions to both clinical and translational science.
Spotify | Apple | Amazon Music | YouTube | Download MP3 (36 mins)
Shaji Kumar
Shaji Kumar is a Consultant in the Division of Hematology at the Mayo Clinic in Rochester, Minnesota, USA, and a Professor of Medicine at the Mayo Clinic College of Medicine and Science. Kumar holds leadership roles in multiple research initiatives, including serving as Chair of the Myeloma, Amyloidosis, and Dysproteinemia Group.
Shaji’s research focuses on hematology and oncology, with a particular emphasis on multiple myeloma, and he has made significant contributions to clinical and translational science. He is also actively involved in numerous national and international clinical trials as both investigator and coordinator, and beyond his professional work, is passionate about travel and photography.
Timestamps:
00:00 – Introduction
02:23 – Drug combinations and myeloma biology
08:34 – Treating newly diagnosed multiple myeloma
17:24 – Quadruplet regimens
23:09 – Clinical trials for plasma cell malignancies
28:04 – The bone marrow microenvironment in multiple myeloma
30:29 – “Blind men and an elephant”
33:58 – Kumar’s three wishes for healthcare
